J. Prat

Reproductive Medicine · 2000–2019

A researcher in the Science corpus: 4 papers; trusts 3 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

Whom J. Prat trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. R. Kurman
  2. Ie-Ming Shih
  3. C. Lord

Who trusts J. Prat overall

  1. Hodgkin Lymphoma
  2. S. Lheureux

Papers from J. Prat's perspective

Ordered by how strongly the researchers J. Prat trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer (Journal of Pathology)
  2. The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome (American Journal of Surgical Pathology)
  3. A candidate precursor to serous carcinoma that originates in the distal fallopian tube
  4. Grading Ovarian Serous Carcinoma Using a Two-Tier System (American Journal of Surgical Pathology)
  5. ARID1A mutations in endometriosis-associated ovarian carcinomas. (New England Journal of Medicine)
  6. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy (Nature)
  7. Mutation of the PIK3CA Gene in Ovarian and Breast Cancer (Cancer Research)
  8. The Origin and Pathogenesis of Epithelial Ovarian Cancer- a Proposed Unifying Theory (American Journal of Surgical Pathology)
  9. Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship (American Journal of Surgical Pathology)
  10. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer. (Journal of the National Cancer Institute)

Their papers